Financials
Financial year 2025
SA PHARMA from Oudergem, company number BE1004498643, closed financial year 2025 with a result of € 54,394 after tax. For that financial year SA PHARMA recorded a gross margin of € 68,746 and equity of € 123,278. Compared with financial year 2024, the result moved from € 55,717 to € 54,394. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 6, 2026.
€ 123,278
▲ 79% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 54,394
▼ 2% vs 2024
Profit after tax over the fiscal year.
€ 109,994
▲ 48% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 109,278.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 630
Supplier invoices still open on the last day of the fiscal year.
€ 29,947
▼ 9% vs 2024
Taxes, VAT and social contributions still to pay.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 71,657 | € 68,746 | ▼ 4% |
| Profit after taxes | € 55,717 | € 54,394 | ▼ 2% |
| Equity | € 68,884 | € 123,278 | ▲ 79% |
| Total debts | € 33,659 | € 30,577 | ▼ 9% |
| Cash | € 74,205 | € 109,994 | ▲ 48% |
| Retained profit | € 54,884 | € 109,278 | ▲ 99% |
| Dividend | € 833 | € 0 | ▼ 100% |
| Balance sheet total | € 102,543 | € 153,855 | ▲ 50% |
Key figures of SA PHARMA, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SA PHARMA?
What happened at SA PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 54,394 (▼ 2% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Oudergem. KBO
In short
From € 55,717 profit in 2024 to € 54,394 profit in 2025.
Paid € 27,753 in corporate taxes since 2024.
Best year ever: 2024, with € 55,717 profit.
Paid out € 833 in dividends to the owners in total.
Establishments
Establishment units
Physical locations of this company
Waverse steenweg 1676 box 6
1160 Oudergem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →Syndicat de Défense contre les Bruits d'Avion
Shilla
€ 524,544 gross margin · 2024
AZ-SA
€ 70,026 revenue · 2025
ORGATRADE
€ 12,288 gross margin · 2025
Advays
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- ARBAOUI Samia(comparant, souscripteur) 100%
Details
- Company number
- 1004.498.643
- VAT number
- BE 1004.498.643
- Registered office
- Waverse steenweg 1676 bus 6, 1160 Oudergem
- Names & denominations
- SA PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 January 2024
- Peppol
- Active · Active since 28 Jan 2026
- Activities · NACE
Handel in eigen onroerend goed
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Verhuur en exploitatie van terreinen
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Overige gespecialiseerde wetenschappelijke en technische activiteiten